| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | myricetin | CTRPv2 | pan-cancer | AAC | -0.0097 | 0.8 |
| mRNA | ibrutinib | CTRPv2 | pan-cancer | AAC | 0.011 | 0.8 |
| mRNA | BRD-K09344309 | CTRPv2 | pan-cancer | AAC | 0.021 | 0.8 |
| mRNA | dabrafenib | CTRPv2 | pan-cancer | AAC | 0.012 | 0.8 |
| mRNA | crizotinib:PLX-4032 (2:1 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.0084 | 0.8 |
| mRNA | cediranib | CTRPv2 | pan-cancer | AAC | 0.013 | 0.8 |
| mRNA | PF-184 | CTRPv2 | pan-cancer | AAC | 0.008 | 0.8 |
| mRNA | Fumonisin B1 | CTRPv2 | pan-cancer | AAC | -0.0088 | 0.8 |
| mRNA | erismodegib | CTRPv2 | pan-cancer | AAC | -0.0089 | 0.8 |
| mRNA | Teniposide | CTRPv2 | pan-cancer | AAC | -0.0094 | 0.8 |